First American Bank’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,439
Closed -$241K 261
2020
Q4
$241K Buy
+3,439
New +$141K 0.02% 237
2019
Q1
Sell
-9,637
Closed -$219K 322
2018
Q4
$219K Sell
9,637
-3,481
-27% -$94.7K 0.02% 291
2018
Q3
$417K Buy
+13,118
New +$424K 0.03% 256
2018
Q1
$285K Hold
8,608
0.02% 276
2017
Q4
$265K Sell
8,608
-362
-4% -$9.12K 0.02% 290
2017
Q3
$215K Sell
8,970
-6,000
-40% -$114K 0.02% 316
2017
Q2
$251K Buy
+14,970
New +$270K 0.02% 291

Other funds holding EDIT

First American Bank's EDIT Position: Q1 2021 in Review

First American Bank sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 3,439 shares — an estimated $241K sold.

First American Bank first reported a position in EDIT in Q2 2017 and held it in 7 quarters. The position peaked at $417K in Q3 2018. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

  • First American Bank reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
  • First American Bank sold 3,439 Editas Medicine shares in Q1 2021, an estimated $241K.
  • First American Bank first reported a position in Editas Medicine in Q2 2017 and held it in 7 quarters.
  • First American Bank's Editas Medicine position peaked at $417K in Q3 2018.
  • 312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on First American Bank's 13F filing for Q1 2021, filed 8 Apr 2021.